ndx-4 Antibody

What is NDX-4 and why are NDX antibodies significant in plant biology research?

NDX-4 (also known as enhancer of coolair1-4 or eoc1-4) refers to a mutation in the Arabidopsis nodulin homeobox protein AtNDX. AtNDX functions as a negative regulator in the abscisic acid (ABA) signaling pathway, which is crucial for plant responses to environmental stresses. NDX antibodies are invaluable tools for detecting and studying AtNDX protein levels, localization, and interactions, enabling researchers to investigate its role in developmental processes and stress responses .

Methodologically, NDX antibodies allow for the detection of both wild-type and mutant variants through various applications including immunoblotting, which is essential for confirming the presence or absence of functional AtNDX protein in experimental plant lines. These antibodies have been instrumental in characterizing mutant phenotypes by confirming reduced protein levels in ndx-4, ndx-5, and ndx-6 mutant lines .

What experimental techniques are compatible with NDX antibodies?

NDX antibodies have proven effective across multiple experimental platforms in plant molecular biology research. These include:

• Western blotting (immunoblot assays) - For quantitative detection of AtNDX protein levels in various plant tissues and genotypes

• Chromatin immunoprecipitation (ChIP) - For identifying genomic regions bound by AtNDX when used with epitope-tagged versions (e.g., GFP-tagged AtNDX)

• Immunofluorescence - For visualizing subcellular localization of AtNDX protein

When designing experiments, researchers should include appropriate controls to validate antibody specificity, such as recombinant GST-AtNDX-C protein expressed in E. coli, which has been successfully used as a positive control to evaluate NDX antibody specificity .

How can researchers confirm the specificity of NDX antibodies?

Confirming antibody specificity is critical for reliable experimental outcomes. For NDX antibodies, researchers should:

• Include positive controls such as purified recombinant NDX protein (GST-AtNDX-C from E. coli has been successfully used)

• Include negative controls such as protein extracts from confirmed ndx knockout lines

• Verify size-appropriate banding patterns in immunoblot assays

• Perform peptide competition assays to confirm epitope specificity

In published work, immunoblot assays using NDX antibodies demonstrated significantly reduced AtNDX levels in ndx-4, ndx-5, and ndx-6 mutants compared to wild-type plants, confirming both the specificity of the antibodies and the impact of these mutations on protein expression .

How can NDX antibodies be used to investigate ABA signaling pathway components?

NDX antibodies serve as powerful tools for unraveling the complex regulatory networks in ABA signaling. Researchers can employ these antibodies to:

• Monitor changes in AtNDX protein levels in response to ABA treatment, which has been shown to downregulate AtNDX expression

• Investigate protein-protein interactions between AtNDX and PRC1 components (AtRING1A and AtRING1B) through co-immunoprecipitation experiments

• Examine the effects of various mutations or environmental conditions on AtNDX stability and function

Methodologically, combining immunoprecipitation with NDX antibodies and subsequent western blotting for interaction partners enables researchers to map the dynamic protein complexes involved in ABA signaling. For example, studies have demonstrated that AtNDX interacts with Polycomb Repressive Complex 1 (PRC1) core components to negatively regulate ABA-responsive genes .

What approaches should be used when designing ChIP experiments with NDX antibodies?

When designing chromatin immunoprecipitation (ChIP) experiments to identify AtNDX binding sites:

• Use epitope-tagged versions of AtNDX (e.g., AtNDX-GFP) for improved ChIP efficiency

• Select appropriate plant tissues and developmental stages where AtNDX is known to be expressed

• Consider crosslinking conditions carefully, as AtNDX binds to both single-stranded and double-stranded DNA with different affinities

• Include controls for non-specific binding, such as IgG antibodies or non-relevant tagged proteins

Previous research successfully employed ChIP-PCR with GFP antibodies in ndx-1 (eoc1-1) mutants complemented with AtNDX-GFP to identify AtNDX binding to the downstream region of ABI4 (approximately 730-1,013 bp from the putative stop codon) .

How can researchers use NDX antibodies to study the relationship between AtNDX and target genes?

To effectively investigate the regulatory relationship between AtNDX and its target genes:

• Combine ChIP using NDX antibodies with qPCR or sequencing to identify direct binding sites

• Correlate binding data with gene expression analysis in wild-type and ndx mutant backgrounds

• Use CRISPR/Cas9-mediated deletion of putative binding regions to confirm functional relevance

• Employ electrophoretic mobility shift assays (EMSA) with recombinant AtNDX protein to validate direct binding in vitro

Research has demonstrated that AtNDX directly binds to the downstream region of ABI4, a key transcription factor in ABA signaling. Deleting this region using CRISPR/Cas9 increased ABA sensitivity in primary root growth and elevated ABI4 expression levels, confirming the functional relevance of this binding site .

What are the optimal conditions for using NDX antibodies in immunoblot assays?

For optimal results with NDX antibodies in immunoblot assays:

• Sample preparation:

  • Extract proteins using a buffer containing appropriate protease inhibitors

  • Normalize protein concentrations across samples (typically 10-20 μg total protein per lane)

• SDS-PAGE conditions:

  • Use 10-12% acrylamide gels for optimal resolution of AtNDX

  • Include positive controls (e.g., recombinant GST-AtNDX-C) and molecular weight markers

• Antibody incubation:

  • Dilute primary NDX antibodies appropriately (optimization may be required)

  • Incubate membranes at 4°C overnight for best results

  • Use appropriate secondary antibodies compatible with detection system

• Detection:

  • Enhanced chemiluminescence (ECL) or fluorescence-based detection systems are suitable

  • Consider longer exposure times if signal is weak

Published research successfully employed NDX antibodies in immunoblot assays to detect significant reductions in AtNDX levels in ndx-4, ndx-5, and ndx-6 mutants compared to wild-type plants .

What are potential pitfalls when using NDX antibodies and how can they be addressed?

Common challenges and solutions when working with NDX antibodies include:

Researchers should validate new batches of NDX antibodies against known positive controls, such as GST-AtNDX-C from E. coli, which has been used successfully to evaluate NDX antibody specificity .

How can researchers optimize ChIP-PCR protocols when using NDX antibodies?

For effective chromatin immunoprecipitation with NDX antibodies:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (1-1.5%) and incubation times

  • Consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde for protein-protein interactions

• Sonication parameters:

  • Optimize sonication conditions to achieve chromatin fragments of 200-500 bp

  • Verify fragment size by agarose gel electrophoresis

• Antibody binding:

  • Pre-clear chromatin with protein A/G beads before adding antibody

  • Incubate with NDX antibodies overnight at 4°C with gentle rotation

  • Consider using tagged versions (e.g., GFP-tagged AtNDX) and corresponding tag antibodies

• Washing and elution:

  • Include stringent washing steps to reduce background

  • Elute DNA using optimized conditions (typically at 65°C)

Previous research successfully employed GFP antibodies with AtNDX-GFP in ChIP-PCR assays to detect significant enrichment around the ABI4 downstream region, demonstrating the effectiveness of this approach when using appropriate controls and optimization .

How can NDX antibodies be used to study interactions between AtNDX and PRC1 components?

To investigate the protein-protein interactions between AtNDX and Polycomb Repressive Complex 1 (PRC1) components:

• Co-immunoprecipitation (Co-IP):

  • Use NDX antibodies to immunoprecipitate AtNDX from plant tissue extracts

  • Detect PRC1 components (AtRING1A and AtRING1B) in the precipitate by western blotting

  • Perform reciprocal Co-IP with antibodies against PRC1 components

• Proximity ligation assay (PLA):

  • Use primary antibodies against AtNDX and PRC1 components

  • Visualize interactions as fluorescent spots using species-specific secondary antibodies linked to DNA probes

• Bimolecular fluorescence complementation (BiFC):

  • Generate fusion constructs of AtNDX and PRC1 components with split fluorescent protein fragments

  • Analyze reconstituted fluorescence upon interaction in planta

Research has demonstrated that AtNDX interacts with PRC1 core components AtRING1A and AtRING1B both in vitro and in vivo, and together they negatively regulate the expression of ABA-responsive genes .

What methodologies are most effective for studying the DNA-binding properties of AtNDX?

To effectively characterize the DNA-binding properties of AtNDX:

• Electrophoretic mobility shift assay (EMSA):

  • Use purified recombinant AtNDX protein (e.g., AtNDX-GST)

  • Test binding to both single-stranded and double-stranded DNA probes

  • Include competition assays with unlabeled probes to confirm specificity

  • Test mutated DNA sequences to identify critical binding motifs

• DNA footprinting:

  • Use DNase I protection assay with labeled DNA fragments

  • Identify protected regions that indicate AtNDX binding sites

• Systematic evolution of ligands by exponential enrichment (SELEX):

  • Identify preferred binding sequences from random oligonucleotide pools

Research has shown that AtNDX can bind to both single-stranded and double-stranded DNA, with stronger affinity for double-stranded DNA. Mutations in TATA or ATTA motifs decreased binding affinity, and AtNDX binding appears to be related to the AT content of the sequence .

How can researchers integrate NDX antibody data with functional genomics approaches?

To maximize the value of NDX antibody-based research:

• Combine ChIP-seq with RNA-seq:

  • Identify genome-wide AtNDX binding sites using ChIP-seq with NDX antibodies

  • Correlate binding sites with transcriptional changes in ndx mutants using RNA-seq

  • Identify direct regulatory targets versus secondary effects

• Integrate with proteomic analyses:

  • Use immunoprecipitation with NDX antibodies followed by mass spectrometry

  • Identify novel interaction partners and post-translational modifications

  • Compare protein interaction networks under different conditions (e.g., ±ABA treatment)

• Connect with genetic analyses:

  • Verify the functional relevance of identified targets through genetic approaches

  • Test epistatic relationships between ndx mutations and mutations in target genes

  • Create reporter constructs to visualize the activity of AtNDX-regulated promoters

Published research has demonstrated the value of integrating multiple approaches, showing that genetic interaction between ndx mutations and abi4 mutations provides functional validation of the regulatory relationship identified through biochemical approaches .

What are emerging applications for NDX antibodies in plant stress response research?

As climate change intensifies research into plant stress responses, NDX antibodies offer significant potential for:

• Investigating AtNDX protein dynamics under various abiotic stresses

• Exploring cross-talk between ABA and other stress-responsive hormonal pathways

• Studying tissue-specific regulation of AtNDX during development and stress responses

• Developing crop improvement strategies based on NDX-regulated pathways

The established role of AtNDX as a negative regulator in ABA signaling positions NDX antibodies as valuable tools for dissecting the molecular mechanisms underlying drought tolerance and stress adaptation in plants .

How can researchers effectively compare data across different NDX antibody-based studies?

To ensure comparability and reproducibility:

• Document and report detailed antibody information including:

  • Source and catalog number

  • Working dilutions and incubation conditions

  • Validation methods employed

• Include standardized controls:

  • Wild-type and ndx-4 mutant samples as positive and negative controls

  • Recombinant protein standards (e.g., GST-AtNDX-C) for calibration

• Employ quantitative approaches:

  • Use digital imaging and analysis software for western blots

  • Include internal loading controls for normalization

  • Report statistical analyses of replicated experiments